- · 《心血管外科杂志(电子版[05/20]
- · 《心血管外科杂志(电子版[05/20]
- · 《心血管外科杂志(电子版[05/20]
- · 《心血管外科杂志(电子版[05/20]
- · 《心血管外科杂志(电子版[05/20]
- · 《心血管外科杂志(电子版[05/20]
高同型半胱氨酸血症与心血管疾病的关系研究进(3)
作者:网站采编关键词:
摘要:[16] 齐国雪,崔莹,严宁,等.同型半胱氨酸经内质网应激介导APOE(-/-)小鼠心肌细胞凋亡及枸杞多糖的干预作用[J].宁夏医科大学学报,2019,41(02):109-113. [17] Yajing
[16] 齐国雪,崔莹,严宁,等.同型半胱氨酸经内质网应激介导APOE(-/-)小鼠心肌细胞凋亡及枸杞多糖的干预作用[J].宁夏医科大学学报,2019,41(02):109-113.
[17] Yajing Huo,Xuqing Wu,Jing Ding,Yang Geng,Weiwei Qiao,Anyan Ge,Cen Guo,Jianing Lv,Haifeng Bao,Wei Fan,Lingyan Remodeling,Oxidative Stress,and Disrupted PPAR γ Expression in Rats of Long-Term Hyperhomocysteinemia with Metabolic Disturbance[J].PPAR Research,2018.
[18] Billel Chaouad,Elara ,Adel Ghoul,Fouzia Zerrouk,Anissa Moulahoum,Khira Othmani-Mecif,Mohamed El Hadi Cherifi,Jean-Marie Exbrayat,Yasmina and myocardial remodeling in the sand rat,Psammomys obesus[J].Acta Histochemi ca,2019,121(7):823-832.
[19] Familtseva A,Jeremic N,Kunkel GH,et receptor 4 mediates vascular remodeling in hyperhomocysteinemia[J].Mol Cell Biochem,2017,433(1-2):177-194.
[20] 韦玉鲁.高同型半胱氨酸血症与脑血管疾病相关研究进展[J].医学理论与实践,2019,32(07):968-969+972.
[21] Chengguo Liu,Xiaohui Sun,Hanli Lin,Ruizhi Zheng,Liansheng Ruan,Zhanhang Sun,Yimin between hyperhomocysteinemia and metabolic syndrome with early carotid artery atherosclerosis: A crosssectional study in middle-aged Chinese population[J].Nutrition,2018(53):115-119.
[22] 于博文,武琛,薛哲,等.血清同型半胱氨酸水平与颈动脉内-中膜厚度的相关分析[J].中国现代神经疾病杂志,2019,19(01):37-40.
[23] 彭红艳,李小晶,贾海珍,等.超声造影时间一强度曲线分析冠心病患者颈动脉斑块内新生血管与高同型半胱氨酸的关系[J].重庆医学,2019,48(1):64-66.
[24] Karadeniz M,Sarak T,Duran M,et Predicts the Severity of Coronary Artery Disease as Determined by the SYNTAX Score in Patients with Acute Coronary Syndrome[J].Acta Cardiol Sin,2018,34(6):458-463.
[25] 刘祥红,师志云,刘会玲,等.不同类型冠心病患者血清同型半胱氨酸水平变化研究[J].中国全科医学,2019,22(8):920-924.
[26] 李富利,赵艳军,张爱文,等.血浆同型半胱氨酸水平与急性心肌梗死冠状动脉病变程度的相关性研究[J].河北医药,2019,41(16):2459-2461,2465.
[27] Chan SH,Hung CH,Shih JY,et intervention attenuates hyperhomocysteinemia-induced aortic endothelial oxidative injury by regulating SIRT1 through mitigating NADPH oxidase/LOX-1 signaling[J].Redox Biology,2018(14):116-125.
[28] Fan J,Zheng F,Li S,et sulfide lowers hyperhomocysteinemia dependent on cystathionine γ lyase S-sulfhydration in ApoE-knockout atherosclerotic mice[J].Br J Pharmacol,2019,176(17):3180-3192.
[29] Yi Fu,Yu S u n,M e n g Z h o u,Xia oji e W a n g,Ziy in g Wang,Xinbing Wei,Yan Zhang,Zeyu Su,Kaili Liang,Wei Tang,Fan Potential of Progranulin in Hyperhomocysteinemia-Induced Cardiorenal Dysfunction[J].Hypertension,2017,69(2):259-266.
[30] Reule CA,Goyvaerts B,Schoen of an L-argininebased multi ingredient product on endothelial function in subjects with mild to moderate hypertension and hyperhomocysteinemia - a randomized,doubleblind,placebocontrolled,cross-over trial[J].BMC Complement Altern Med,2017,17(1):92.
[31] Peng Y,Ou BQ,Li HH,et Effect of Atorvastatin and Folic Acid on Cardiac Function and Ventricular Remodeling in Chronic Heart Failure Patients with Hyperhomocysteinemia[J].Med Sci Monit,2018(24):3744-3751.
[32] Liu DS,Gao W,Liang ES,et of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunc tion[J].Eur J Pharmacol,2017,14(1-3):163-169.
[33] Liu DS,Wang SL,Li JM,et improves carotid artery intima-media thickness in coronary artery disease patients with hyperhomocysteinemia[J].Exp Ther Med,2017,14(2):1722-1726.
[34] Qiu LH,Zhang BQ,Lian MJ,et protective effects of Astragalus membranaceus and its main constituents in rats with chronic hyperhomocysteinemia[J].Exp Ther Med,2017,14(3):2401-2407.
[35] Martí-Carvajal Arturo J,Solà Ivan,LathyrisDimitrios,Dayer interventionsfor preventing cardiovascular events[J].The Cochranedatabase of systematic reviews,2017(8):CD006612.
文章来源:《心血管外科杂志(电子版)》 网址: http://www.xxgwkzz.cn/qikandaodu/2021/0727/762.html